Comparison of High-Specific-Activity Ultratrace (123/131)I-MIBG and Carrier-Added (123/131)I-MIBG on Efficacy, Pharmacokinetics, and Tissue Distribution.
| Autor: | Barrett JA, Joyal JL, Hillier SM, Maresca KP, Femia FJ, Kronauge JF, Boyd M, Mairs RJ, Babich JW |
|---|---|
| Zdroj: | Cancer Biotherapy & Radiopharmaceuticals; Jun2010, Vol. 25 Issue 3, p299-308, 10p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|